Elsevier

Neuroscience Letters

Volume 341, Issue 1, 24 April 2003, Pages 65-68
Neuroscience Letters

The effects of diazepam on sensory gating in healthy volunteers

https://doi.org/10.1016/S0304-3940(03)00155-1Get rights and content

Abstract

Sensory or P50 gating, as measured with the double click paradigm, reflects a slow inhibitory preattentional information process. It protects living organisms from being flooded by environmental stimuli. The effects of a single dose of diazepam (10 mg) on the amplitude of the P50’s and P50 gating, as measured from auditory evoked potentials elicited by double clicks (80 dB white noise, interstimulus interval 500 ms) were investigated in a double blind, placebo controlled study in healthy volunteers. P50 gating was found, however diazepam had no effects on the amplitude of the P50, nor on P50 gating. The results contribute to the specificity of psychoactive drugs to control gating and demonstrate that this slow inhibitory process is not effected by this benzodiazepine. Moreover, the results confirm that P50 and P50 gating are indeed preattentive processes that are not controlled by diazepam.

References (20)

There are more references available in the full text version of this article.

Cited by (9)

  • Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers

    2014, Psychiatry Research
    Citation Excerpt :

    This result is likely to be attributable to the sedative and anxiolytic actions of the hormone, as the startle response is known to be potentiated by fear and or anxiety (Davis, 1993). Various other sedative compounds, such as benzodiazepines (Abduljawad et al., 1997; van Luijtelaar, 2003) but also the atypical antipsychotics clozapine (Graham et al., 2001) and quetiapine (Graham et al., 2004), have demonstrated to reduce raw startle amplitudes in healthy subjects, whereas opposite effects were observed with the anxiogenics amphetamine (Davis et al., 1975; Swerdlow et al., 1990) and yohimbine (Davis and Astrachan, 1981; Morgan et al., 1993). Alternatively as stated above, melatonin increases D1/D2 activity but decreases noradrenergic activity.

  • Hallucinations and negative symptoms differentially revealed by frontal and temporal responses to speech in schizophrenia

    2014, Schizophrenia Research
    Citation Excerpt :

    The difference could not be attributed to treatment received by the patients. Indeed, benzodiazepines and neuroleptics have been reported to have no effect on the characteristics of P1 (Moxon et al., 2003; van Luijtelaar, 2003). The auditory P1 or P50 is the first positive deflection of the auditory ERPs recorded at fronto-central sites.

  • Impaired P50 suppression in fear extinction in obsessive-compulsive disorder

    2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • Towards a functional topography of sensory gating areas: Invasive P50 recording and electrical stimulation mapping in epilepsy surgery candidates

    2007, Psychiatry Research - Neuroimaging
    Citation Excerpt :

    However, in a recent surface study from our group comparing patients with focal lobe epilepsy to healthy controls (Boutros et al., 2006), P50 auditory gating did not differ significantly between the groups. As for effects of drug treatment, to the best of our knowledge, there is only one study examining the effects of anticonvulsant agents on P50 sensory gating (Van Luijtelaar, 2003). In that study, application of a single dose of diazepam to healthy individuals did not alter P50 gating.

  • P50 sensory gating in panic disorder

    2006, Journal of Psychiatric Research
View all citing articles on Scopus
View full text